Jeito Capital co-leads $110 Million Series A Financing in Neogene Therapeutics

Paris, France, Sept. 14 (Korea Bizwire) – Jeito Capital (“Jeito”), a rapidly emerging independent investor dedicated to biotech and biopharma, today announced that it has co-led a $110 million Series A financing in Neogene Therapeutics, Inc. (“Neogene”), a pre-clinical stage biotechnology company pioneering a new class of fully personalized neo-antigen T cell therapies to treat cancer. [...]